Menopause apps eased hot flashes and trimmed waists, but left blood pressure alone

The menopausal transition brings bothersome symptoms such as hot flashes, disturbed sleep and low mood, and it coincides with rising cardiometabolic risk. Yet access to evidence-based non-pharmacological support remains limited for many women. Digital health interventions, delivered through apps and online programmes, promise an accessible and scalable route to symptom management, but whether they actually work has remained uncertain. This review set out to pool the randomised trial evidence and test what these tools genuinely deliver, both for symptoms and for heart and metabolic health.

The reviewers searched eleven databases from their inception to August 2025 for randomised controlled trials of digital health interventions in women undergoing the menopausal transition. Eighteen trials met the criteria, together enrolling 1926 participants. Results were pooled using random-effects models with a statistical adjustment designed to guard against overconfident estimates, and two reviewers independently assessed the quality of each trial and the certainty of the overall evidence. Outcomes spanned menopausal symptoms, including hot flashes, night sweats, sleep and depressive symptoms, alongside cardiometabolic measures such as body weight, waist circumference, blood pressure, lipids and glycaemic markers.

Digital interventions reduced hot-flash frequency, improved sleep quality scores by 3.38 points, and trimmed waist circumference by 2.23 cm compared with control conditions. For depressive symptoms, the pooled estimate favoured the digital programmes but fell short of statistical significance and did not hold up when higher-risk trials were excluded. There were no significant effects on night sweats, body weight, body fat percentage, body mass index, blood pressure, lipid profiles, heart rate or glycaemic outcomes. Certainty of the evidence was moderate for hot flashes, low for waist circumference and depressive symptoms, and very low for sleep quality.

Digital tools are increasingly pitched at midlife women, so a pooled verdict on what they deliver is overdue. This analysis suggests the symptom benefits are real but selective: hot flashes and possibly sleep respond, while the broader hope of cardiometabolic improvement finds little support beyond waist circumference. The uneven certainty across outcomes means several findings could shift as better trials arrive. The authors call for longer interventions tested in clearly defined menopausal populations, using standardised and, where feasible, objective outcome measures.

If hot flashes or poor sleep are the problem, this is evidence that an app or online programme can help, with the hot-flash finding resting on the firmest ground. The waist circumference result is intriguing but carried low certainty, and nothing here suggests these tools will move blood pressure, cholesterol or blood sugar. Digital support is not a replacement for medical care, but as an accessible first step for managing menopausal symptoms, the pooled evidence now leans in its favour.